NRx Pharmaceuticals, Inc.
NRx Pharmaceuticals, Inc. scores highest on Torque (92) and lowest on Price (0). Its PosiPenta is 47.08 out of 100, around the middle of similar companies.
On the Penta Grid this week, NRx Pharmaceuticals, Inc. is Grid #333 of 837 in the Healthcare sector in United States, and Grid #2,200 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| NRx Pharmaceuticals, Inc. | 47.08 | 0 | 55 | 54 | 92 | 35 |
| The Joint Corp. | 54.78 | 20 | 86 | 50 | 66 | 52 |
| OnKure Therapeutics, Inc. | 46.61 | 46 | 40 | 30 | 65 | 53 |
| LifeMD, Inc. | 30.86 | 5 | 75 | 16 | 15 | 43 |
| LENZ Therapeutics, Inc. | 36.11 | 46 | 30 | 8 | 62 | 35 |
| Apyx Medical Corporation | 31.36 | 7 | 43 | 42 | 19 | 46 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -4.48 |
| P/B ratio | -662.17 |
EEarnings
| Trailing EPS | ₹-54.93 |
| Forward EPS | ₹-33.15 |
NNitro
| Price | 246.26 |
| 52-week high | 478.78 |
| 52-week low | 153.44 |
| Fall from 52-week high | 48.6% |
TTorque
| Return on equity (ROE) | — |
| Debt-to-equity | -0.04 |
AAnchor
| Beta (price swings) | 2.07 |
| Market cap | ₹1,066 Cr |
| Insider holding | 4.12% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is NRx Pharmaceuticals, Inc.'s PosiPenta score?
NRx Pharmaceuticals, Inc.'s PosiPenta is 47.08 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does NRx Pharmaceuticals, Inc. stand on the Penta Grid?
On the Penta Grid this week, NRx Pharmaceuticals, Inc. is Grid #333 of 837 in the Healthcare sector in United States, and Grid #2,200 of 4,000 in United States.
Which PosiPenta pillar is strongest for NRx Pharmaceuticals, Inc.?
Torque (durability), with a score of 92 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for NRx Pharmaceuticals, Inc.?
Price (valuation), with a score of 0 out of 100: much weaker than most similar companies.
Has NRx Pharmaceuticals, Inc.'s PosiPenta changed since last week?
Yes, it rose 3.18 points, from 43.90 to 47.08.
PositoAI is for research and education only and is not investment advice.